Key Features

• Arintra is a GenAI-native platform combines large language models with clinical knowledge graphs to read a closed patient chart in full clinical context (rather than keyword-matching) and autonomously apply specialty-specific CPT, ICD-10, HCC, and HCPCS codes; this description of the underlying technical approach was independently corroborated by HIT Consultant's reporting on the company's August 2026 Series B.
• The vendor states 82–86% of coded charts "flow through" automatically straight to claim submission, with the remainder routed to the customer's existing coder work queues along with a full explanation for review; every generated code is stated to trace back to the specific documentation passages that justify it, forming a chart-level audit trail inside the EHR.
• Arintra received an overall performance score of 93 out of 100 in a 2026 KLAS Research Emerging Company Spotlight report - exceeding the 2026 Best in KLAS software average of 81.1, with a specific A+ grade on partnership/transparent pricing and A grades on solution capabilities and likelihood to recommend. KLAS also reported that 100% of interviewed customer organizations had adopted direct-to-bill autonomous coding, across customers on both Epic and athenahealth.
• Its platform supports 23+ specialties across ambulatory, emergency, diagnostic, and inpatient care settings using "one model" rather than separate point solutions per setting.

Compliance & Security

• HIPAA Compliance: Yes
• FDA Status: Not applicable. Arintra is administrative/financial medical-coding and revenue-cycle software, not a clinical device; no FDA filing was found or would be expected for this product category.
• Security certifications: HITRUST e1 certification and SOC 2 compliance

Integration & Workflow

• EHR: Integrates with Epic, athenahealth, eClinicalWorks, Oracle Cerner EHR, Meditech, NextGen Healthcare, and Allscripts
• Platform: Embedded directly inside the customer's existing EHR workflow - providers document as they always have, with no new tool or added clicks, and coded charts write back into the EHR automatically, with exceptions routed to coders' existing work queues within that same EHR.
• Onboarding/setup: A named customer (Meritus, per a CIO testimonial on the homepage) reported being "live within two months," and a separate named customer (Vanova Health, per an independently syndicated PR Newswire release) reported reaching 85% coding automation within four weeks of go-live and more than 50,000 charts autonomously coded since a December 2025 implementation - these are named, single-customer implementation timelines rather than a general vendor-stated SLA.

Pricing & Access

• Not publicly listed; the vendor directs prospective customers to "Book Demo" rather than publishing pricing, consistent with an enterprise health-system sales model. (KLAS's independent report separately gave Arintra an A+ grade specifically on "fair and transparent charging" based on customer interviews, though the actual rates themselves remain non-public.)
• No free trial is advertised on the vendor's public site, consistent with an enterprise sales motion.

Doxiverse Assessment: Strengths & Limitations

• Strengths: Arintra has an unusually strong combination of independent validation for a company at this stage - a genuine, non-vendor-controlled KLAS Research score (93/100, above the Best-in-KLAS average) based on customer interviews, primary-source confirmation of both an Epic Toolbox and athenahealth Marketplace listing (not just a vendor's own claim), and a HITRUST e1 certification independently confirmed via wire press. Its recently closed $25M Series B (bringing total funding to $51M, led by Define Ventures with participation from Peak XV Partners, Y Combinator, and new strategic investors including Yale New Haven Ventures) - suggests continued institutional backing and runway. Coverage spanning ambulatory, emergency, diagnostic, and inpatient settings with "one model" is a genuinely broader scope claim than several narrower point-solution competitors profiled elsewhere in this directory (e.g., XpertDox, which is explicitly outpatient/ambulatory-focused).
• Limitations/Risks: As with most vendors in this directory, headline percentage statistics tied to named customer case studies (5.1% revenue uplift, 43% denial reduction, 64%+ reduction in pre-A/R days, 88% direct-to-billing automation) are individual customer results or company-wide averages presented in marketing materials rather than independently audited by a third party outside of the KLAS report itself; a buyer's own results will depend on specialty mix, payer mix, and starting baseline. Pricing is entirely non-public, consistent with an enterprise, demo-gated sales process.

Ideal User Profile

• Best for: Enterprise health systems and larger physician groups with coding volume spanning multiple care settings (ambulatory, emergency, diagnostic, inpatient) and multiple specialties.
• Not ideal for: Small independent practices without the scale to engage in an enterprise sales/demo process.

Disclaimer - This profile was compiled from publicly available sources including the vendor's own website, regulatory filings, press coverage, and independent research. Vendor claims are labeled as such and have not been independently audited by Doxiverse. Product features, pricing, certifications, and regulatory status change frequently and may no longer be current; verify all details directly with the vendor before making a purchasing decision. The "Doxiverse Assessment" and "Ideal User Profile" sections reflect Doxiverse's independent editorial analysis based on available sources at the time of writing, not the vendor's endorsement, and the vendor may disagree with this characterization. This profile is provided for informational purposes only and does not constitute a recommendation, endorsement, or professional/legal/clinical advice. Report inaccuracies to contact@doxiverse.com